Pictet Asset Management Holding SA Cuts Stake in Astera Labs, Inc. $ALAB

Pictet Asset Management Holding SA cut its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 25.3% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 55,968 shares of the company’s stock after selling 19,001 shares during the quarter. Pictet Asset Management Holding SA’s holdings in Astera Labs were worth $6,134,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Lido Advisors LLC raised its stake in shares of Astera Labs by 0.5% in the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after acquiring an additional 57 shares in the last quarter. Perigon Wealth Management LLC increased its holdings in Astera Labs by 6.2% during the 4th quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock worth $208,000 after purchasing an additional 73 shares during the period. Sound Income Strategies LLC increased its holdings in Astera Labs by 9.2% during the 4th quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after purchasing an additional 76 shares during the period. Venturi Wealth Management LLC raised its position in Astera Labs by 2.6% in the 4th quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock valued at $546,000 after purchasing an additional 84 shares in the last quarter. Finally, Goldstein Advisors LLC raised its position in Astera Labs by 5.8% in the 4th quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock valued at $268,000 after purchasing an additional 88 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling

In other Astera Labs news, CEO Jitendra Mohan sold 325,693 shares of the stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02. Following the transaction, the chief executive officer directly owned 4,079,322 shares in the company, valued at $702,214,489.08. This represents a 7.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the sale, the chief operating officer directly owned 5,064,213 shares in the company, valued at approximately $1,470,141,033.90. The trade was a 7.32% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,981,441 shares of company stock valued at $444,969,514 over the last ninety days. 10.40% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts have recently issued reports on ALAB shares. Evercore reiterated an “outperform” rating and issued a $297.00 price objective on shares of Astera Labs in a research note on Tuesday, May 19th. Stifel Nicolaus raised their target price on shares of Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a report on Wednesday, June 24th. TD Cowen lifted their price target on shares of Astera Labs from $140.00 to $225.00 and gave the stock a “hold” rating in a research note on Wednesday, May 6th. Northland Securities cut shares of Astera Labs from an “outperform” rating to a “market perform” rating in a report on Tuesday, May 26th. Finally, Weiss Ratings raised shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Twelve equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $265.75.

Astera Labs Price Performance

Shares of NASDAQ ALAB opened at $406.42 on Friday. The business has a 50-day moving average of $314.72 and a two-hundred day moving average of $205.55. The company has a market capitalization of $69.66 billion, a price-to-earnings ratio of 274.61, a price-to-earnings-growth ratio of 4.66 and a beta of 3.66. Astera Labs, Inc. has a 1 year low of $88.18 and a 1 year high of $499.48.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same quarter in the prior year, the business posted $0.33 EPS. The business’s revenue for the quarter was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities research analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.